Publication & Citation Trends
Publications
441 total
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer PDF
Cited by 218
OpenAlex
PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
Cited by 245
OpenAlex
Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01) PDF
Cited by 231
OpenAlex
Research Topics
HER2/EGFR in Cancer Research
(85)
Cancer Genomics and Diagnostics
(82)
Cancer Treatment and Pharmacology
(49)
PI3K/AKT/mTOR signaling in cancer
(47)
Breast Cancer Treatment Studies
(45)
Affiliations
AstraZeneca (United Kingdom)
University of Southern California
Roche (Switzerland)
University of Maryland, Baltimore
National Academy of Medicine